Clinical Trial: Systemic Immune-Inflammation Index and Platelet Parameters in Diabetic Kidney Disease

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773467) titled 'Systemic Immune-Inflammation Index and Platelet Parameters in Diabetic Kidney Disease' on Aug. 15.

Brief Summary: Diabetic kidney disease (DKD) is a frequent microvascular complication in individuals with type 2 diabetes mellitus (T2DM) and a major cause of chronic kidney failure worldwide. Chronic low-grade inflammation and platelet activation contribute significantly to renal microvascular damage.

The purpose of this observational study is to evaluate whether routine blood test markers, specifically the Systemic Immune-Inflammation Index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and platelet...